Home-based biofeedback therapy is effective option for tough-to-treat constipation
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Oct. 22, 2018) - Biofeedback therapy used at home is about...
HIV-infected Hispanic adults face higher risks of HPV-related cancers
A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers...
Heredity matters: Ancestral protease functions as protein import motor in chloroplasts
Credit: Osaka University Osaka, Japan -- Over 1 billion years ago, a relationship began between the ancestor of all living...
New treatment approach for advanced anal cancer
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP)...
Future fertility: Giving hope to men who received childhood cancer treatment
Credit: Dong-Ha Bhang, Penn Medicine: Nature Communications PHILADELPHIA - Researchers have discovered a way to grow human stem cells destined...
Oncologists demand more education on the use of biosimilars: ESMO takes action
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines...
Multi-strain probiotic reduces chemotherapy-induced diarrhoea [ESMO 2018 Press Release]
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A high concentration of multi-strain probiotic helps...
Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
Munich, Germany, 20 October 2018 - Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the...
Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors...
Targeting specific genomic mutation in breast cancer improves outcomes, first study shows
(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced...
Bright lights, big CITI
Credit: Duke-NUS Medical School Singapore, 22 October 2018 - Global efforts in immuno-oncology have received a major boost, with a...
Immunotherapy may become new first line treatment in some metastatic colorectal cancers
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Immunotherapy with nivolumab and low-dose ipilimumab could...
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Pre-operative treatment with a combination of the...
Abramson Cancer Center receives $10.7 million to study CAR T cells in solid tumors
PHILADELPHIA - A new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center...
A dog’s color could impact longevity, increase health issues
New research led by the University of Sydney has revealed the life expectancy of chocolate Labradors is significantly lower than...
Labrador retrievers at risk of various health problems
Labrador retrievers, the second most popular dog breed in the UK, are vulnerable to a number of health conditions, according...
Wishful thinking is rewarded
We make judgements quite rationally or "by the gut". Not only experience and relevant information play an important role, but...
Researchers discovered a new mechanism of action in a first-line drug for diabetes
Credit: Lehtonen Lab / University of Helsinki For decades, metformin has been the first-line drug in the treatment of type...
New agent against anthrax
A team led by Professor Arne Skerra at the Technical University of Munich (TUM) has developed an innovative strategy for...
Social stigma contributes to poor mental health in the autistic community
Stress related to social stigma may be the reason why autistic people experience more mental health problems than the general...
